UK Peptide Research Blog
Explore peptide testing, documentation and published research with Edinburgh Peptide. These articles explain laboratory evidence and research terminology; they do not provide medical advice.
Analytical Methods · Quality & Documentation · Laboratory Practice · Compound Research · Research Evidence · UK Buying & Product Information
-
Co-Elution: When One Chromatographic Peak Is Not One Compound
A single chromatographic peak may contain more than one substance. Co-elution complicates purity interpretation because separation and detection have limits. Learn how alternative chromatographic conditions, spectral evidence and focused follow-up questions help…
-
How Detector Response Changes an HPLC Result
An HPLC peak area is a detector response before it becomes a chemical conclusion. Wavelength, molecular composition and calibration determine what that response can support. This guide explains why seemingly similar chromatograms…
-
Assay Versus Purity: Specifying Peptide Content
A peptide assay and an HPLC purity percentage can describe different quantities. Understanding the reporting basis helps researchers connect a weighed sample with the amount of target material, recognise missing measurements and…
-
Planning Peptide Solution Preparation in a Laboratory
Identify the documentation, compatibility, measurement and record-keeping questions that belong in a laboratory-specific solution-preparation plan.
-
Peptide Storage: Build a Product-Specific Handling Record
Plan peptide storage around the exact formulation, container and supporting data, with clear records instead of a universal temperature or shelf-life rule.
-
Before Choosing a Research Supplier: Build a Document Trail
Use identity, traceability, test scope and practical delivery information to organise a supplier assessment without relying on badges or broad quality claims.
-
GHK-Cu Research: Why Chemical Form and Study Design Both Matter
Distinguish GHK from copper-associated forms, and read cell-culture findings without treating them as evidence for finished products or clinical use.
-
BPC-157 and TB-500: Model Selection Matters More Than a Shared Category
Compare the questions asked in BPC-157 and TB-500 studies, including model limitations and the importance of precise material identification.
-
Tesamorelin and GHRH Analogues: How to Read the Research Context
Assess tesamorelin studies by population, formulation, endpoints and limitations, and distinguish clinical research from a laboratory catalogue entry.
-
MOTS-c Research: From a Mitochondrial Sequence to a Testable Question
Read MOTS-c research through its experimental models, molecular identity and study limitations without treating preclinical findings as clinical claims.
-
Research Use Only: Separating Catalogue Information from Clinical Evidence
Understand the difference between a research catalogue entry, a scientific finding and evidence or authorisation for a clinical use.
-
Why “99% Purity” Is Not a Complete Peptide Specification
Learn why chromatographic purity, peptide quantity, identity and contamination testing must not be treated as interchangeable measurements.